Par To Market Generic Imitrex Through Deal With Spectrum
This article was originally published in The Pink Sheet Daily
Executive Summary
Spectrum and Par believe they will be entitled to 180-day exclusivity on the pending Imitrex injection generic.
You may also be interested in...
Imitrex Patent Settlement Allows For Entry During Pediatric Exclusivity Period
Spectrum/Par say launch of subcutaneous sumatriptan could come as early as Aug. 6, 2008.
Imitrex Patent Settlement Allows For Entry During Pediatric Exclusivity Period
Spectrum/Par say launch of subcutaneous sumatriptan could come as early as Aug. 6, 2008.
Generic Flonase To Launch Immediately
Approval of Roxane’s fluticasone propionate nasal spray had been delayed since November due to GSK citizen petitions.